Business
AbCellera to Present at Upcoming Investor Conferences in September
VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that executives from the Company will be presenting at the following
About this update from Abcellera Biologics Inc.
[{"type":"text","content":" VANCOUVER, British Columbia--(BUSINESS WIRE)--\nAbCellera (Nasdaq: ABCL) today announced that executives from the Company will be presenting at the following investor conferences:\n\n\n\nWells Fargo Healthcare Conference on Thursday, September 5, 2024, at 12:00 p.m. Pacific Time (3:00 p.m. Eastern Time)\n\n\n\nCantor Global Healthcare Conference on Tuesday, September 17, 2024, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time)\n\n\n\nLive audio webcasts of each presentation may be accessed through links that will be posted on AbCellera's Investor Relations website. Replays of each webcast will be available through the same links following the presentations.\n\n\nAbout AbCellera Biologics Inc.\n\n\nAbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas, including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20240829861441/en/\n\nInquiries\n\n\nMedia: Kathleen Reid; [email protected], +1(236)521-6774\nBusiness Development: Murray McCutcheon, Ph.D.; [email protected], +1(604)559-9005\nInvestor Relations: Melanie Solomon; [email protected], +1(778)729-9116\n\n\nSource: AbCellera Biologics Inc.","length":3876,"tagName":"div"}]